139 related articles for article (PubMed ID: 25047671)
1. [Pristinamycin/Vitamin k antagonists drug interaction: a French pharmacovigilance database study].
Guiboux AL; Dautriche A; Rocher F; Bruel M; Sgro C;
Therapie; 2014; 69(5):391-4. PubMed ID: 25047671
[TBL] [Abstract][Full Text] [Related]
2. Pristinamycin-induced arthralgia and myalgia: Analysis of the French Pharmacovigilance Database.
Denis Prevot M; Thillard EM; Walther J; Veyrac G; Laroche ML; Gautier S; Auffret M
Med Mal Infect; 2018 Feb; 48(1):58-62. PubMed ID: 29110913
[TBL] [Abstract][Full Text] [Related]
3. Probable interaction between an oral vitamin K antagonist and turmeric (Curcuma longa).
Daveluy A; Géniaux H; Thibaud L; Mallaret M; Miremont-Salamé G; Haramburu F
Therapie; 2014; 69(6):519-20. PubMed ID: 25230280
[TBL] [Abstract][Full Text] [Related]
4. [Management of vitamin K antagonists in the elderly].
Belleville T; Pautas É; Gaussem P; Siguret V
Ann Biol Clin (Paris); 2014; 72(2):185-92. PubMed ID: 24736138
[TBL] [Abstract][Full Text] [Related]
5. [A case of yellow urticaria].
Benamara-Lévy M; Samimi M; Georgescou G; Moënne-Loccoz J; Maruani A
Presse Med; 2015 Jan; 44(1):122-3. PubMed ID: 25065659
[No Abstract] [Full Text] [Related]
6. [Submacular hemorrhage with retinal detachment due to an overdose of anticoagulant during age-related macular degeneration].
Grondin C; Pascal ML; Bourdon H; Vu Q; Beaujeux P; Koch E
J Fr Ophtalmol; 2019 Feb; 42(2):215-218. PubMed ID: 30679121
[No Abstract] [Full Text] [Related]
7. [Vitamine K antagonists overdose: Physician adherence to the French guidelines].
Oliosi E; Pointeau O; Mazoyer E; Le Jeune S; Giroux-Leprieur B; Dhôte R; Mourad JJ
Rev Med Interne; 2018 May; 39(5):321-325. PubMed ID: 29550092
[TBL] [Abstract][Full Text] [Related]
8. [New oral anticoagulants (NOACs): happy or not happy?].
Bergmann JF
Presse Med; 2013 Oct; 42(10):1295-7. PubMed ID: 24160349
[No Abstract] [Full Text] [Related]
9. [Vitamin K antagonist-induced necrotic leg ulcer, without protein C and S deficiencies].
Kurihara F; Tella E; Sigal ML; Mahé E
Rev Med Interne; 2018 Jan; 39(1):50-53. PubMed ID: 28867534
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of patients' knowledge on their vitamin K antagonist treatment.
Mzoughi K; Zairi I; BenGhorbel F; Ben Kilani M; Kamoun S; Ben Moussa F; Fennira S; Kraiem S
Tunis Med; 2018 Mar; 96(3):182-186. PubMed ID: 30325485
[TBL] [Abstract][Full Text] [Related]
11. [Educational and information needs of patients under vitamin K antagonist therapy].
Ben Jeddou K; Ben M'Barka F; Boukhris I; Arfaoui H; Baccar H; Khalfalah N; Ouhachi Z
Rev Med Interne; 2018 Jul; 39(7):546-550. PubMed ID: 29789192
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and management of antivitamin K overdose in a hospital setting.
Zemouri A; Lin F; Billuart O; Sacco E; Emmerich J; Priollet P; Yannoutsos A
J Med Vasc; 2021 Jul; 46(4):175-181. PubMed ID: 34238512
[TBL] [Abstract][Full Text] [Related]
13. [Is the use of vitamin K antagonists harmful in patients with CDK?].
Pham TT; Saudan P
Rev Med Suisse; 2012 Feb; 8(330):462-5. PubMed ID: 22452132
[TBL] [Abstract][Full Text] [Related]
14. [Anticoagulant clinics are they effective in France? Performance evaluation of six anticoagulant clinics concerning the management of vitamin K antagonists].
Cambus JP; Magnin D; Ambid-Lacombe C; Bura A; Desgrippes F; Schneller JM; Benhamou Y; Flaujac C; Horellou MH; De Raucourt E; Kaczan D; Astoul JM; Siguret V
Rev Med Interne; 2013 Sep; 34(9):515-21. PubMed ID: 23523077
[TBL] [Abstract][Full Text] [Related]
15. [Heterogeneity in the handling of vitamin-K-antagonists and of INR: the example of Quercy-Rouergue].
Watine J; Mokaddem W; Carriere P; Couaillac JP; Kristoffersen AH; Thue G; Sandberg S
Ann Biol Clin (Paris); 2013; 71(6):707-16. PubMed ID: 24342793
[TBL] [Abstract][Full Text] [Related]
16. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
[TBL] [Abstract][Full Text] [Related]
17. Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database.
Fournier JP; Sommet A; Durrieu G; Poutrain JC; Lapeyre-Mestre M; Montastruc JL;
Fundam Clin Pharmacol; 2014 Apr; 28(2):230-5. PubMed ID: 23190210
[TBL] [Abstract][Full Text] [Related]
18. Nonhemorrhagic joint disorders and vitamin K antagonists: an under-recognized adverse drug reaction?
Béné J; Rousselin C; Bagheri H; Vial T; Gautier S; Lambert M
Fundam Clin Pharmacol; 2018 Dec; 32(6):663-668. PubMed ID: 29729202
[TBL] [Abstract][Full Text] [Related]
19. Thromboembolic outcomes after use of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal in a real-world setting.
Joseph R; Burner J; Yates S; Strickland A; Tharpe W; Sarode R
Transfusion; 2016 Apr; 56(4):799-807. PubMed ID: 26589481
[TBL] [Abstract][Full Text] [Related]
20. [Massive right auricular and ventricular thrombosis after Kaskadil administration in a patient with an overdose of antivitamin K].
Bonnet A; Rimmelé T; Crozon J; Pruvot S
Ann Fr Anesth Reanim; 2008 Apr; 27(4):348-9. PubMed ID: 18403177
[No Abstract] [Full Text] [Related]
[Next] [New Search]
